Sinovac Biotech Ltd (SVA): Net Income
-$198.84M
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$198.84M | n/m | 2026-06-05, From 2025-01-01 |
| 2024-12-31 | $40.66M | n/m | 2026-06-05, From 2024-01-01 |
| 2023-12-31 | -$120.86M | n/m | 2026-06-05, From 2023-01-01 |
| 2022-12-31 | -$59.97M | n/m | 2026-04-30, From 2022-01-01 |
| 2021-12-31 | $14.12B | n/c | 2026-04-30, From 2021-01-01 |
| 2020-12-31 | $185.18M | +184.0% | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | $65.22M | +80.6% | 2022-04-29, From 2019-01-01 |
| 2018-12-31 | $36.11M | -1.6% | 2021-04-22, From 2018-01-01 |
| 2017-12-31 | $36.70M | n/m | 2020-04-30, From 2017-01-01 |
| 2016-12-31 | -$720.0K | n/m | 2019-04-29, From 2016-01-01 |
| 2015-12-31 | -$957.0K | n/m | 2018-05-11, From 2015-01-01 |
| 2014-12-31 | -$1.25M | n/m | 2017-11-22, From 2014-01-01 |
| 2013-12-31 | $10.37M | n/m | 2016-04-25, From 2013-01-01 |
| 2012-12-31 | -$18.75M | n/m | 2015-04-29, From 2012-01-01 |
| 2011-12-31 | -$399.0K | n/m | 2014-04-16, From 2011-01-01 |
| 2010-12-31 | -$12.60M | n/m | 2013-05-23, From 2010-01-01 |
| 2009-12-31 | $30.41M | n/a | 2012-04-12, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$198.84M | n/m |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$16.14M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$61.60M | n/m |
| Innoviva, Inc. (INVA) | 2025-12-31 | $271.17M | n/m |
| MannKind Corp (MNKD) | 2025-12-31 | $5.86M | -78.7% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | -$175.54M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $163.06M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $20.45M | +159.1% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | -$25.55M | n/m |
Compare SVA, ARQT, ARDX, INVA side by side · Screen every company in Pharmaceutical Preparations ↗